{
  "id" : "ss2018_cervix_64954",
  "algorithm" : "eod_public",
  "version" : "1.2",
  "name" : "SS2018: Cervix",
  "title" : "Summary Stage 2018: Cervix",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Cervix**\n\n8000-8700, 8720-8790, 8805, 8933, 8980, 9110, 9581, 9700-9701\n\nC530-C531, C538-C539\nC530 Endocervix\nC531 Exocervix\nC538 Overlapping lesion of cervix\nC539 Cervix uteri\n\n**Note 1:** The following sources were used in the development of this chapter\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 52 *Cervix Uteri*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** See the following chapters for the listed histologies \n* 8710-8714, 8800-8804, 8806-8932, 8934, 8940-8975, 8981-9105, 9120-9137, 9141-9580, 9582: *Soft Tissue*\n* 8935-8936: *GIST*\n* 9140: *Kaposi Sarcoma*\n\n**Note 3:** Para-aortic nodes are now regional instead of distant.",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging.** In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631\n\n(6) Erickson, B.A., Olawaiye, A.B., Mutch, D.G., et al. **Cervix Uteri**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 649-659",
  "last_modified" : "2018-05-09T15:33:19.336Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "0", "In situ, intraepithelial, noninvasive \n- Cancer in situ WITH endocervical gland involvement\n- Cervical intraepithelial neoplasia (CIN) Grade III\n- Preinvasive" ], [ "1", "Localized only (localized, NOS)\n- FIGO Stage IA1\n  + Measured stromal invasion 3.0 mm or less and 7.0 mm or less in horizontal spread\n- FIGO Stage IA2\n  + Measured stromal invasion 3.1 mm to 5.0 mm with a horizontal spread of 7.0 mm or less\n- FIGO Stage IA [NOS]\n  + Measured stromal invasion 5.0 mm or less measured from the base of the epithelium AND horizontal spread of 7.0 mm or less\n- FIGO Stage IB\n- FIGO Stage I [NOS]\n  + Clinically visible lesion (macroscopic), including superficial invasion\n  + Confined to cervix uteri or uterus, NOS, except corpus uteri, NOS\n     * (Not clinically visible or unknown if clinically visible)" ], [ "2", "Regional by direct extension only\n- FIGO Stage IIA, IIB, II [NOS]\n  + Confined to corpus uteri, size, depth and horizontal spread unknown\n  + Corpus uteri, NOS \n  + Cul de sac (rectouterine pouch) \n  + Invasion beyond uterus, NOS\n  + Ligament(s) (broad, cardinal, uterosacral)\n  + Parametrial (paracervical soft tissue) invasion\n  + Upper two-thirds of vagina including fornices\n  + Vagina, NOS\n  + Vaginal wall, NOS\n- FIGO Stage IIIA\n  + Bladder wall\n  + Bladder, NOS excluding mucosa\n  + Bullous edema of bladder mucosa\n  + Lower third of vagina \n  + Rectal wall\n  + Rectum, NOS excluding mucosa\n  + Ureter, intra- and extramural\n  + Vagina, lower third (not extending to pelvic wall)\n  + Vulva\n- FIGO Stage IIIB\n  + Described clinically as frozen pelvis\n  + Hydronephrosis or nonfunctioning kidney\n  + Pelvic wall(s)\n- FIGO Stage III [NOS]\n  + Fallopian tube(s)\n  + Ovary(ies)\n  + Urethra" ], [ "3", "Regional lymph node(s) involved only\n- Aortic\n  + Lateral aortic\n  + Para-aortic\n  + Periaortic\n- Iliac, NOS\n  + Common\n  + External\n  + Internal (hypogastric) (obturator), NOS\n- Paracervical\n- Parametrial\n- Pelvic, NOS\n- Sacral, NOS\n  + Lateral (laterosacral)\n  + Middle (promontorial) (Gerotaâ€™s node)\n  + Presacral\n  + Uterosacral\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s)/lymph node(s) involved\n- Distant site(s) (including further contiguous extension)\n  + Bladder mucosa \n  + Rectal mucosa\n  + Sigmoid colon\n  + Small intestine\n  + FIGO Stage IVA, IVB, IV [NOS]\n- Distant lymph node(s), NOS \n  + Inguinal\n  + Mediastinal\n  + Scalene\n  + Supraclavicular\n- Distant metastasis, NOS\n  + Carcinomatosis \n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}